- change ups
Items Tagged with 'pharmaceuticals'
Allegan-based Perrigo has begun what it claims is the first broad marketing and communications campaign to raise consumer awareness of, and confidence in, generic over-the-counter medications sold by major retailers under their own store brands. Read More
Perrigo (Nasdaq: PRGO) has signed a merger agreement and completed the acquisition of Leeds, U.K.-based Rosemont Pharmaceuticals Ltd. for approximately £180 million or $283 million in cash. Read More
Perrigo has signed a definitive agreement to acquire Velcera Inc. — an OTC pet health-products company in Yardley, Pa. — for $160 million in cash, with the acquisition expected to close this year. Read More
Allegan pharmaceutical manufacturer Perrigo (Nasdaq: PRGO) has announced it has signed a definitive merger agreement and completed full acquisition of Cobrek Pharmaceuticals Inc., a privately-held, Chicago based drug development company, for approximately $45 million on a cash free and debt-free basis. Read More
Perrigo has announced that its partner, Cobrek Pharmaceuticals Inc., has received final approval from the U.S. Food and Drug Administration for its generic equivalent to Luxiq, a foam treatment for scalp psoriasis, with Perrigo now set to begin commercial shipments of it in mid January. Read More
Perrigo (Nasdaq:PRGO), the Allegan-based global company that is among the world’s largest manufacturers of over-the-counter pharmaceuticals, has just reported adjusted net income in the first quarter of a record $119 million or $1.27 per diluted share. Management has also raised Perrigo’s adjusted EPS guidance for the new fiscal year to reflect the acquisition of Sergeant’s Pet Care Products. Read More